Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karl Gaffney

Showing results (1-10 of 77) with videos related to

Pageof 8
Sort By:
Clinical Medicine (London, England)|November 1, 2011
Factors influencing recruitment to rheumatologyPippa Watson, Karl Gaffney
The Journal of Rheumatology|August 3, 2017
Maintenance of Low Disease Activity following Tumor Necrosis Factor Inhibitor Dose Tapering in Ankylosing SpondylitisLauren Steel, Karl Gaffney
Rheumatology (Oxford, England)|June 27, 2018
Scrotal calcinosis in an adult patient with amyopathic dermatomyositisLauren Steel, Karl Gaffney
Clinical Medicine (London, England)|July 14, 2005
Management of early rheumatoid arthritisShirish Dubey, Karl Gaffney
Joint Bone Spine|December 12, 2018
The Tuck sign-proliferative extensor tenosynovitis of the wristKaterina M Achilleos, Karl Gaffney
Current Opinion in Rheumatology|May 11, 2021
Inflammatory back pain: a concept, not a diagnosisFiona Louise Coath, Karl Gaffney
Annals of the Rheumatic Diseases|April 9, 2014
Comment on: 'Diagnostic delay in patients with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis: results from the Danish nationwide DANBIO registry' by Sørensen et alMark Sykes, Helen Doll, Karl Gaffney
Rheumatology (Oxford, England)|December 15, 2015
Do low-dose anti-TNF regimens have a role in patients with ankylosing spondylitis?Max Yates, Andrew Keat, Karl Gaffney
Best Practice & Research. Clinical Rheumatology|September 1, 2023
Diagnostic delay in axial spondylarthritis: A lost battle?Rosemarie Barnett, Karl Gaffney, Raj Sengupta
Rheumatology Advances in Practice|August 22, 2019
Exploring sub-optimal response to tumour necrosis factor inhibitors in axial spondyloarthritisFariz Yahya, Karl Gaffney, Raj Sengupta
Pageof 8

Showing results (1-10 of 77) with videos related to

Sort By:
Pageof 8
Clinical Medicine (London, England)|November 1, 2011
Factors influencing recruitment to rheumatologyPippa Watson, Karl Gaffney
The Journal of Rheumatology|August 3, 2017
Maintenance of Low Disease Activity following Tumor Necrosis Factor Inhibitor Dose Tapering in Ankylosing SpondylitisLauren Steel, Karl Gaffney
Rheumatology (Oxford, England)|June 27, 2018
Scrotal calcinosis in an adult patient with amyopathic dermatomyositisLauren Steel, Karl Gaffney
Clinical Medicine (London, England)|July 14, 2005
Management of early rheumatoid arthritisShirish Dubey, Karl Gaffney
Joint Bone Spine|December 12, 2018
The Tuck sign-proliferative extensor tenosynovitis of the wristKaterina M Achilleos, Karl Gaffney
Current Opinion in Rheumatology|May 11, 2021
Inflammatory back pain: a concept, not a diagnosisFiona Louise Coath, Karl Gaffney
Annals of the Rheumatic Diseases|April 9, 2014
Comment on: 'Diagnostic delay in patients with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis: results from the Danish nationwide DANBIO registry' by Sørensen et alMark Sykes, Helen Doll, Karl Gaffney
Rheumatology (Oxford, England)|December 15, 2015
Do low-dose anti-TNF regimens have a role in patients with ankylosing spondylitis?Max Yates, Andrew Keat, Karl Gaffney
Best Practice & Research. Clinical Rheumatology|September 1, 2023
Diagnostic delay in axial spondylarthritis: A lost battle?Rosemarie Barnett, Karl Gaffney, Raj Sengupta
Rheumatology Advances in Practice|August 22, 2019
Exploring sub-optimal response to tumour necrosis factor inhibitors in axial spondyloarthritisFariz Yahya, Karl Gaffney, Raj Sengupta
Pageof 8